Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Sep;26(5):503-507.

A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema

Affiliations
Case Reports

A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema

Oleksander Prylutskyi et al. Ethiop J Health Sci. 2016 Sep.

Abstract

Background: Autoimmune polyglandular syndrome type 2 represents an uncommon endocrine disorder composed by Addison's disease with autoimmune thyroid disease (Schmidt's syndrome) and/or type 1 diabetes mellitus. Scleromyxedema is a rare progressive cutaneous mucinosis usually associated with systemic involvement and paraproteinemia. To the best of our knowledge, there is no case report of Schmidt's syndrome associated with scleromyxedema.

Case details: A 34-year-old woman was admitted to Donetsk Clinical Territorial Medical Association due to acute general weakness, reduced vision, dryness of integuments, memory decline, fatigue, weight loss, rash on the face trunk and extremities. A diagnosis of APS type II was made comprising of autoimmune hypothyroidism and autoimmune adrenal insufficiency. Skin histopathologic examination demonstrated the presence of mucin deposits, dermal fibrosis, fibrocytes and perivascular inflammation. In the absence of monoclonal paraproteinemia and the presence of typical histological and clinical signs, an atypical form of scleromyxedema was diagnosed. The patient was administered a lifetime replacement levothyroxine and methylprednisolone therapy.

Conclusion: Identification and adequate treatment of both APS type II and scleromyxedema in affected patients pose a problem due to the lack of facilities for diagnosis and management plus common misdiagnosis. Early diagnosis should be made before the development of life-threatening complications.

Keywords: Addison's disease; Autoimmune polyglandular syndrome type II; Autoimmune thyroiditis; Scleromyxedema atypical form.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Papular skin eruption in a linear pattern on the upper trunk
Figure 2
Figure 2
“Doughnut sign” on the metacarpophalangeal joint
Figure 3
Figure 3
Leonine facies

References

    1. Anyfantakis D, Symvoulakis EK, Vourliotaki I, Kastanakis S. Schmidt's syndrome presenting as a generalised anxiety disorder: a case report. Journal of Medicine and Life. 2013;6(4):451–453. - PMC - PubMed
    1. Kahaly GJ. Polyglandular autoimmune syndromes. European Journal of Endocrinology. 2009;161:11–20. - PubMed
    1. Majeroni PA, Patel P. Autoimmune polyglandular syndrome type II. Am Fam Physician. 2007;75:667–677. - PubMed
    1. Brown-Falco O, Burgdorf WHC, Wolff HH, Landthaaler M. Dermatology. Czelej, Lublin. 2011:1289–1290.
    1. Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxodematosus and scleromyxedema. J Am Acad Dermatol. 2001;44:273–281. - PubMed

Publication types

LinkOut - more resources